脑缺血/再灌对蒙古沙土鼠海马突触体酪氨酸磷酸化的影响

用蒙古沙土鼠双侧颈总动脉结扎（ＢＣＡＯ）前脑缺血模型,研究缺血／再灌对海马突触体蛋白酪氨酸磷酸休的影响及ＮＭＤＡ受体（ＮＲ）非竞争性拮抗剂氯胺酮（Ｋｅｔａｍｉｎｅ,ＫＴ）、Ｌ－型电压门控钙离子通道（Ｌ－ｔｙｐｅ ｖｏｌｔａｇｅ ｇａｔｅｄｃａｌｃｉｕｍ ｃｈａｎｎｅｌ,Ｌ－型ＶＧＣＣ）拮抗剂硝苯吡啶（ｎｉｆｅｄｉｐｉｎｅ,ＮＤ）及非ＮＲ拮抗６,７－二硝基喹恶啉上卫四（６,７－ｄｉ－ｎｉｔｒｏｐｕ     

一氧化氮在心肌缺血再灌注损伤中的作用

目的：观察一氧化氮（NO）对相对缺血再灌注心肌损伤的保护作用。方法：高频弱电流刺激法建立离体心肌相对缺血再灌注模型,设非缺血组和相对缺血组,相对缺血组包括对照、L－精氨酸（L－ARG）、硝基－L－精氨酸甲酯（L－NAME）三组。测定缺血前和再灌注时心功能变化、NO含量和乳酸脱氢酶同工酶－1（LD－1）活性。结果：L－ARG可明显促进再灌注期间NO合成,抑制D－1活性升高。再灌注40min时,L－ARG组心肌功能恢复程度明显高于对照组和L－NAME组（P＜0.05）,L－NAME使心肌NO含量降低（P＜0.05）,LD－1活性升高（P＜0.05）,心功能恢复程度最低。结论：NO可明显减轻心肌缺血再灌注时的细胞损伤,促进心功能的恢复。     

缺血引起沙土鼠纹状体DARPP—32磷酸化状态的变化

采用蒙古沙土双侧颈总动脉阻断前脑缺血模型,以放射自显影（反向磷酸化,back-phosphorylation)及免疫印迹（Western blotting)法体外测定缺血时纹状体DARPP－32磷酸化水平和蛋白含量的变化,结果表明,短暂性缺血纹状体DARPP－32的免疫学活性和蛋白含量地明显改变。在缺血10min内,随缺血时间的延长,体外DARPP－32的[^32P]的掺入量在缺血5min时升高,在缺血2,7,10min时均降低,而反向磷酸化的测定结果表明体内DARPP－32磷酸化水平增高,说明缺血可诱导DARPP－32磷酸化水平变化。     

茶多酚对沙土鼠脑缺血后再灌注氧化损伤的保护作用

采用蒙古沙土鼠（Ｇｅｒｂｉｌ）制作脑缺血后再灌注模型,用化学发光法（Ｃｈｅｍｉｌｕｍｉｎｓｃｅｎｅ,ＣＬ）测定缺血后再灌注、喂饲茶多酚后脑组织内源性超氧化物歧化酶（ＳＯＤ）的活性、脂质过氧化程度（ＬＰＯ）及脑组织ＡＴＰ能量代谢的变化;运用顺磁共振法（ＥＳＲ）检测了缺血后再灌注过程中产生的活性氧（ＲｅａｃｔｉｖｅＯｘｙｇｅｎＳｐｅｃｉｅｓ,ＲＯＳ）,探讨了脑缺血后再灌注的损伤机制及抗氧化剂的保护作用。在整体模型的研究中表明,茶多酚对沙土鼠脑缺血后再灌注氧化损伤具有显著的保护作用;内源性超氧化物歧化酶活性提高,脂质过氧化程度下降,ＡＴＰ水平升高     

高压氧对脑缺血再灌注海马神经元Bcl-2和Bax蛋白表达的影响

目的：进一步探讨高压氧治疗脑缺血再灌注损伤,减轻神经元调亡朋而发挥保护作用的机理。方法：采用“双侧颈总动脉阻断法”前脑缺血模型,对沙土鼠前脑缺血２０ｍｉｎ后再灌注３ｄ,并用０．１５ＭＰａ和０．２５ＭＰａ压力的高压氧治疗（６０ｍｉｎ／ｄ,连续３ｄ）后,应用免疫组化ＬＳＡＢ方法,观察高压氧对海巴ＣＡ１,区神经元凋亡相关基因ｂｃｌ－２和ｂａｘ的蛋白表达的影响。结果：沙土鼠脑缺血再灌注３ｄ组海马ＣＡ１区大     

两类Ca^2＋通道拮抗剂对脑缺血时Ca^2＋／CaM PKhⅡ活性抑制的保护 …

本文以蒙古沙土鼠双颈总动脉结扎（ＢＣＡＯ）前脑缺血模型Ｃａ＾２＋／ＣａＭ ＰＫⅡ活性变化为指标,研究了以氯胺酮（ＫＴ）、右美沙芬（ＤＭ）、苄丙咯（ＢＰ）及硝苯吡啶（ＮＤ）为代表的配体门控Ｃａ＾２＋通道（ＬＧＣＣ）及电压门控Ｃａ＾２＋通道（ＶＧＣＣ）两类Ｃａ＾２＋通道拮抗剂对缺血性脑损伤的保护作用。结果如下：（１）脑缺血后,胞浆型及颗粒型Ｃａ＾２＋／ＣａＭ ＰＫⅡ活性均明显下降;（２）缺血前单独用药     

大鼠脑缺血再灌注血管壁NOS和ICAM-1的表达

一氧化氮（NO）和一氧化氮合酶（NOS）与脑血管功能有重要关系,细胞间粘附分子1（ICAM－1）可由脑缺血／再灌注诱导产生并与脑组织损伤密切相关,本实验用免疫组织化学和NADPH－d酶组织化学方法,观察了SD大鼠实验性脑缺血再灌注内皮细胞ICAM－1和NOS的表达,结果显示正常对照组大鼠脑血管ICAM－1免疫组织化学显色为阴性或弱阳性反应,再灌注2h,ICAM－1阳性反应明显增强,与对照组相比,P＜0.01。随再灌注至16h,ICAM－1表达增加近一倍。脑缺血1h缺血侧侧脑血管壁开始出现NOS的阳性表达,与对照组相比,P＜0.01,再灌注2h,NOS表达最多,随后逐渐下降,结果提示脑缺血再灌注与ICAM－1和NOS表达升高有关。     

亚低温减少沙土鼠脑缺血后延迟性神经元死亡机制的研究

目的：研究亚低温对脑缺血后延迟性神经元死亡的影响及其与海马羟自由基产生以及纹状体多巴胺和ＡＴＰ含量变化的关系。方法：沙土鼠前脑缺血再灌注模型,缺血１０ｍｉｎ,应用病理检查方法判断海马ＣＡｌ锥体细胞死亡的数目。动物随机分为假手术组、缺血组、缺血再灌注组和亚低温缺血再灌注组。高效液相加电化学检测器方法测定海马羟自由基和纹状体多巴胺的含量,高效液相紫外检测器法测定纹状体ＡＴＰ含量。结果：亚低温条件下沙土     

美满霉素对沙鼠急性脑缺血后脑皮质小白蛋白表达的影响

目的：观察美满霉素对蒙古沙鼠短暂性脑缺血再灌后前额皮质中小白蛋白Parvalbumin（PV）表达的影响,为进一步研究其生理功能变化及治疗提供参考。方法：42只健康雄性蒙古沙鼠随机分为：正常组对照组（6只）、缺血再灌组（18只）,美满霉素治疗组（18只）。夹闭蒙古沙鼠双测颈总动脉10min诱导前脑缺血后,动物分别存活1天、3天或7天。用免疫组化方法检测前额皮质中PV的表达,用图像分析仪测定灰度值。结果：与正常组相比,各缺血再灌组与美满霉素治疗组中前额皮质中PV表达均先减少后回升。缺血再灌1天组,PV表达缓慢减少（P〉0.05）;3天组PV表达减少到低谷（P〈0.05）;7天组PV表达有明显的恢复,但仍低于正常组（P〈0.05）;然而美满霉素治疗各组中的PV表达均强于对应的缺血组（P〈0.05）。结论：美满霉素能抑制蒙古沙鼠脑缺血再灌注后脑皮质中小白蛋白的表达,发挥脑保护作用。     

异氟烷预处理对大鼠肝缺血再灌注时脑线粒体钙及线粒体转运通道的影响

目的：通过观察在体大鼠肝部分缺血再灌注损伤后脑线粒体游离钙、线粒体转运通道（ mitochondrial permeability transition pore ,MPTP）及外周血中S-100β蛋白含量的变化,明确异氟烷预处理对大鼠肝部分缺血再灌注时脑损伤是否具有保护作用及可能的机制。方法 SD大鼠75只随机分成假手术组（ S组）;缺血再灌注组（ I/R组）：肝缺血60 min,再灌注120 min;异氟烷预处理组（ ISO组）：肝I/R前60 min ISO预处理30 min,后用空气洗脱30 min：CsA＋ISO组,CsA50 mg/kg静脉内注射,30 min后同ISO组;CsA组,I/R前30 min CsA50 mg/kg静脉内注射。再灌注24 h迅速断头取前脑,分离线粒体进行线粒体游离钙、MPTP含量检测,各组分别于缺血前及再灌注120 min后抽取静脉血采用双抗体夹心-ELAISA 法测定 S-100β蛋白含量。结果 I/R组（287.32±26.17）线粒体游离Ca2＋浓度明显增加,高于S组（198.54±21.02）和ISO组（209.74±29.49）（P ＜0.05）;CsA＋ISO（267.31±37.52）明显高于ISO组（ P ＜0.05）;CsA（288.63±23.15）组与I/R组间比较差异无显著意义（ P ＜0.05）;I/R组（1.73±0.24）的ΔS与S组（2.36±0.35）和ISO 组（2.11±0.32）相比明显减少（P ＜0.05）,既MPTP大量开放,而后两组的差异无统计学意义（P ＜0.05）;I/R组与CsA＋ISO组（1.72±0.34）和CsA组（1.77±0.35）△S之间差异无统计学意义（P ＜0.05）;CsA＋ISO组的ΔS值与ISO组相比明显降低（P ＜0.05）。外周血液S-100β蛋白I/R组明显高于S组和ISO组（P ＜0.05）;CsA＋ISO组与ISO组比较显著升高（P ＜0.05）,I/R组,CsA＋ISO组和CsA组与缺血前比较明显升高（ P ＜0.05）,缺血前S-100β蛋白含量五组无显著性差异（ P ＜0.05）。结论大鼠肝部分缺血再灌注后对脑组织造成了一定程度损伤,而异氟烷预处理对此损伤具有一定保护作用;其作用的机制可能与异氟烷抑制MPTP开放,降低线粒体游离Ca2＋浓度,防止了线粒体Ca2＋超载有关。     

Expression of NMDA neuroreceptors in experimental ischemia

The role of NMDA receptors in molecular mechanisms of neurotoxicity was investigated using rat models of global and focal cerebral ischemia. Expression of NR2A and NR2B receptor mRNAs up-regulated in cortex after 3 h of reperfusion following middle cerebral artery occlusion (MCAo). This effect was accompanied by an increase in NR2A and NR2B immunoreactivity. At six hours of reperfusion, drastic activation of NR2A mRNA expression was observed in the penumbra that returned to the control level at 24 h of reperfusion. The monitoring of NR2A autoantibodies in the blood of the experimental rats showed its reliable increase to the 5-6th day of reperfusion that maintained elevated to the 20th day of the experiment. The data indicate that NR2A and 2B receptor subunits and NR2A autoantibodies are biochemical markers of the neurotoxicity underlying cerebral ischemia.     

mGluR1 antagonist decreases tyrosine phosphorylation of NMDA receptor and attenuates infarct size after transient focal cerebral ischemia

The contribution of metabotropic glutamate receptors to brain injury after in vivo cerebral ischemia remains to be determined. We investigated the effects of the metabotropic glutamate receptor 1 (mGluR1) antagonist LY367385 on brain injury after transient (90 min) middle cerebral artery occlusion in the rat and sought to explore their mechanisms. The intravenous administration of LY367385 (10 mg/kg) reduced the infarct volume at 24 h after the start of reperfusion. As the Gq-coupled mGluR1 receptor is known to activate the PKC/Src family kinase cascade, we focused on changes in the activation and amount of these kinases. Transient focal ischemia increased the amount of activated tyrosine kinase Src and PKC in the post-synaptic density (PSD) at 4 h of reperfusion. The administration of LY367385 attenuated the increases in the amounts of PSD-associated PKCγ and Src after transient focal ischemia. We further investigated phosphorylation of the NMDA receptor, which is a major target of Src family kinases to modulate the function of the receptor. Transient focal ischemia increased the tyrosine phosphorylation of NMDA receptor subunits NR2A and NR2B. Tyrosine phosphorylation of NR2A, but not that of NR2B, in the PSD at 4 h of reperfusion was inhibited by LY367385. These results suggest that the mGluR1 after transient focal ischemia is involved in the activation of Src, which may be linked to the modification of properties of the NMDA receptor and the development of cerebral infarction.     

Transient Ischemia Differentially Increases Tyrosine Phosphorylation of NMDA Receptor Subunits 2A and 2B

Abstract: Activation of the N -methyl- d -aspartate (NMDA) receptor has been implicated in the events leading to ischemia-induced neuronal cell death. Recent studies have indicated that the properties of the NMDA receptor channel may be regulated by tyrosine phosphorylation. We have therefore examined the effects of transient cerebral ischemia on the tyrosine phosphorylation of NMDA receptor subunits NR2A and NR2B in different regions of the rat brain. Transient (15 min) global ischemia was produced by the four-vessel occlusion procedure. The tyrosine phosphorylation of NR2A and NR2B subunits was examined by immunoprecipitation with anti-tyrosine phosphate antibodies followed by immunoblotting with antibodies specific for NR2A or NR2B, and by immunoprecipitation with subunit-specific antibodies followed by immunoblotting with anti-phosphotyrosine antibodies. Transient ischemia followed by reperfusion induced large (23–29-fold relative to sham-operated controls), rapid (within 15 min of reperfusion), and sustained (for at least 24 h) increases in the tyrosine phosphorylation of NR2A and smaller increases in that of NR2B in the hippocampus. Ischemia-induced tyrosine phosphorylation of NR2 subunits in the hippocampus was higher than that of cortical and striatal NR2 subunits. The enhanced tyrosine phosphorylation of NR2A or NR2B may contribute to alterations in NMDA receptor function or in signaling pathways in the postischemic brain and may be related to pathogenic events leading to neuronal death.     

Low Dose ZD7288 Attenuates the Ischemia/Reperfusion-Induced Impairment of Long-Term Potentiation Induction at Hippocampal Schaffer Collateral-CA1 Synapses

Focal cerebral ischemia can impair the induction of activity-dependent long-term potentiation (LTP) in the hippocampus. This impairment of hippocampal synaptic plasticity can be caused by excitotoxicity and subsequent perturbation of hippocampal LTP-relevant transmitter systems, which include NR2B and PSD-95. It has been suggested that hyperpolarization-activated cyclic-nucleotide-gated (HCN) channels may play an important role in the control of membrane excitability and rhythmic neuronal activity. Our previous study has indicated that the selective HCN channel blocker ZD7288 can produce a dose-dependent inhibition of the induction of LTP at the Schaffer collateral-CA1 synapse of hippocampus by reducing the amount of glutamate released. It has also been demonstrated that ZD7288 can protect against neuronal injury caused by oxygen glucose deprivation. In the present study, we investigated the effect of ZD7288 on the induction of activity-dependent LTP and the expression of NR2B and PSD-95 after focal cerebral ischemia/reperfusion injury. The results showed that the induction of LTP was significantly impaired and the levels of NR2B and PSD-95 mRNA and protein were markedly decreased in the CA1 region of hippocampus following focal cerebral ischemia/reperfusion injury. Administration of low dose ZD7288 (0.25 μg) at 30 min and 3 h after the onset of ischemia attenuated the impairment of LTP induction and alleviated the NR2B and PSD-95 mRNA and protein down-regulation commonly induced by cerebral ischemia/reperfusion injury. These results suggest that low dose ZD7288 can ameliorate the ischemia/reperfusion-induced impairment of synaptic plasticity in the hippocampal CA1 region.     

Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate

Consistent with previous reports, sphingosine at a high concentration (5 microM) was cardiotoxic as evidenced by increased infarct size in response to ischemia/reperfusion in an ex vivo rat heart. Sphingosine 1-phosphate (S1P) at 5 microM was cardioprotective. However, at a physiologic concentration (0.4 microM) sphingosine as well as S1P was effective in protecting the heart from ischemia/reperfusion injury both when perfused prior to 40 min of ischemia (preconditioning) or when added to reperfusion media following ischemia (postconditioning). Protection by sphingosine and S1P was evidenced with both pre- and post-conditioning by a >75% recovery of left ventricular developed pressure during reperfusion and a decrease in infarct size from 45% of the risk area to less than 8%. When VPC23019, an S1P(1and3)G-protein coupled receptor antagonist, was added to the preconditioning or postconditioning medium along with S1P, it completely blocked S1P-induced protection. However, VPC 23019 did not affect the ability of 0.4 microM sphingosine to either precondition or postcondition hearts. Studies of preconditioning revealed that inhibition of protein kinase C with GF109203X blocked preconditioning by S1P. However, GF109203X did not affect preconditioning by 0.4 microM sphingosine. Likewise, cotreatment with the PI3 kinase inhibitor wortmanin blocked preconditioning by S1P but not by sphingosine. By contrast, inhibition of protein kinase G with KT5823 had no effect on S1P preconditioning but completely eliminated preconditioning by sphingosine. Also, the protein kinase A inhibitory peptide 14-22 amide blocked preconditioning by sphingosine but not S1P. These data reveal for the first time that sphingosine is not toxic at physiologic concentrations but rather is a potent cardioprotectant that utilizes a completely different mechanism than S1P; one that is independent of G-protein coupled receptors and utilizes cyclic nucleotide-dependent pathways.     

Transient ischemia enhances tyrosine phosphorylation and binding of the NMDA receptor to the Src homology 2 domain of phosphatidylinositol 3-kinase in the rat hippocampus

Tyrosine phosphorylation of the NMDA receptor has been implicated in the regulation of the receptor channel. We investigated the effects of transient (15 min) global ischemia on tyrosine phosphorylation of NMDA receptor subunits NR2A and NR2B, and the interaction of NR2 subunits with the SH2 domain of phosphatidylinositol 3-kinase (PI3-kinase) in vulnerable CA1 and resistant CA3/dentate gyrus of the hippocampus. Transient ischemia induced a marked increase in the tyrosine phosphorylation of NR2A in both regions. The tyrosine phosphorylation of NR2B in CA3/dentate gyrus after transient ischemia was sustained and greater than that in CA1. PI3-kinase p85 was co-precipitated with NR2B after transient global ischemia. The SH2 domain of the p85 subunit of PI3-kinase bound to NR2B, but not to NR2A. Binding to NR2B was increased following ischemia and the increase in binding in CA3/dentate gyrus (4.5-fold relative to sham) was greater than in CA1 (1.7-fold relative to sham) at 10 min of reperfusion. Prior incubation of proteins with an exogenous protein tyrosine phosphatase or with a phosphorylated peptide (pYAHM) prevented binding. The results suggest that sustained increases in tyrosine phosphorylation and increased interaction of NR2B with the SH2 domain of PI3-kinase may contribute to altered signal transduction in the CA3/dentate gyrus after transient ischemia.     

8-Br-cADPR, a TRPM2 ion channel antagonist,inhibits renal ischemia–reperfusion injury

The transient receptor potential melastatin-2 (TRPM2) channel belongs to the transient receptor potential channel superfamily and is a cation channel permeable to Na⁺ and Ca ²⁺. The TRPM2 ion channel is expressed in the kidney and can be activated by various molecules such as hydrogen peroxide, calcium, and cyclic adenosine diphosphate (ADP)-ribose (cADPR) that are produced during acute kidney injury. In this study, we investigated the role of 8-bromo-cyclic ADP-ribose (8-Br-cADPR; a cADPR antagonist) in renal ischemia–reperfusion injury using biochemical and histopathological parameters. CD38, cADPR, tumor necrosis factor-α, interleukin-1β, and myeloperoxidase (inflammatory markers), urea and creatinine, hydrogen peroxide (oxidant), and catalase (antioxidant enzyme) levels that increase with ischemia–reperfusion injury decreased in the groups treated with 8-Br-cADPR. In addition, renin levels were elevated in the groups treated with 8-Br-cADPR. Histopathological examination revealed that 8-Br-cADPR reduced renal damage and the expression of caspase-3 and TRPM2. Our results suggest that the inhibition of TRPM2 ion channel may be a new treatment modality for ischemic acute kidney injury.     

Increased phosphorylation of the NR1 subunit of the NMDA receptor following cerebral ischemia

The effects of transient cerebral ischemia on phosphorylation of the NR1 subunit of the NMDA receptor by protein kinase C (PKC) and protein kinase A (PKA) were investigated. Adult rats received 15 min of cerebral ischemia followed by various times of recovery. Phosphorylation was examined by immunoblotting hippocampal homogenates with antibodies that recognized NR1 phosphorylated on the PKC phosphorylation sites Ser890 and Ser896, the PKA phosphorylation site Ser897, or dually phosphorylated on Ser896 and Ser897. The phosphorylation of all sites examined increased following ischemia. The increase in phosphorylation by PKC was greater than by PKA. The ischemia-induced increase in phosphorylation was predominantly associated with the population of NR1 that was insoluble in 1% deoxycholate. Enhanced phosphorylation of NR1 by PKC and PKA may contribute to alterations in NMDA receptor function in the postischemic brain.     

Translocation and Down-Regulation of Protein Kinase C-α, -β, and -γ Isoforms During Ischemia-Reperfusion in Rat Brain

We investigated the distribution of protein kinase C (PKC) isoforms in the subcellular fractions (P1, 1,000-g pellet; P2, 10,000-g pellet; P3, 100,000-g pellet; S, 100,000-g supernatant) of rat forebrain after ischemia or reperfusion by immunoblotting. PKC-delta and -epsilon isoforms were predominant in the P2 (synaptosome-rich) fraction, whereas PKC-alpha, -beta, -gamma, -epsilon, and -zeta isoforms were rich in the S (cytosolic) fraction. With time of ischemia (5-30 min), PKC-alpha, -beta, and -gamma translocated to the P2 and P3 fractions, whereas reperfusion for 60 min after 30 min of ischemia reduced PKC-beta activity greatly and PKC-alpha and -gamma activities to a lesser extent. There was no redistribution of PKC-delta, -epsilon, and -zeta after ischemia or reperfusion. A calpain inhibitor, acetylleucylleucylnorleucinal, inhibited the down-regulation of PKC-beta, through intravenous injection. The PKC translocation to the P2 fraction was accompanied by their dephosphorylation, transition of PKC-alpha from dimer to trimer, and the decrease in activity. These data show that PKC-alpha, -beta, and -gamma isoforms translocate chiefly to the synaptosome in ischemic brain in association with the dephosphorylation, multimeric change, and inactivation, followed by the proteolysis of PKC-beta by calpain after postischemic reperfusion.